Burt AD - Search Results

1

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.

Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP. Albano E, et al. Among authors: burt ad. Gut. 2005 Jul;54(7):987-93. doi: 10.1136/gut.2004.057968. Gut. 2005. PMID: 15951547 Free PMC article.

2

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. McPherson S, et al. Among authors: burt ad. Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077. Gut. 2010. PMID: 20801772

3

Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance.

Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD, Day CP. Newton JL, et al. Among authors: burt ad. Gut. 2008 Jun;57(6):807-13. doi: 10.1136/gut.2007.139303. Epub 2008 Feb 12. Gut. 2008. PMID: 18270241

4

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

Dongiovanni P, Valenti L, Rametta R, Daly AK, Nobili V, Mozzi E, Leathart JB, Pietrobattista A, Burt AD, Maggioni M, Fracanzani AL, Lattuada E, Zappa MA, Roviaro G, Marchesini G, Day CP, Fargion S. Dongiovanni P, et al. Among authors: burt ad. Gut. 2010 Feb;59(2):267-73. doi: 10.1136/gut.2009.190801. Gut. 2010. PMID: 20176643

5

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.

Teli MR, Day CP, Burt AD, Bennett MK, James OF. Teli MR, et al. Among authors: burt ad. Lancet. 1995 Oct 14;346(8981):987-90. doi: 10.1016/s0140-6736(95)91685-7. Lancet. 1995. PMID: 7475591

6

Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Henderson E, Burt AD, Day CP, Anstee QM. McPherson S, et al. Among authors: burt ad. J Hepatol. 2014 May;60(5):1055-62. doi: 10.1016/j.jhep.2014.01.010. Epub 2014 Jan 18. J Hepatol. 2014. PMID: 24445215

7

Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease.

Grove J, Daly AK, Burt AD, Guzail M, James OF, Bassendine MF, Day CP. Grove J, et al. Among authors: burt ad. Gut. 1998 Aug;43(2):262-6. doi: 10.1136/gut.43.2.262. Gut. 1998. PMID: 10189855 Free PMC article.

8

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

Reeves HL, Burt AD, Wood S, Day CP. Reeves HL, et al. Among authors: burt ad. J Hepatol. 1996 Nov;25(5):677-83. doi: 10.1016/s0168-8278(96)80238-8. J Hepatol. 1996. PMID: 8938545 Clinical Trial.

9

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

Parkes J, Roderick P, Harris S, Day C, Mutimer D, Collier J, Lombard M, Alexander G, Ramage J, Dusheiko G, Wheatley M, Gough C, Burt A, Rosenberg W. Parkes J, et al. Gut. 2010 Sep;59(9):1245-51. doi: 10.1136/gut.2009.203166. Epub 2010 Jul 30. Gut. 2010. PMID: 20675693

10

Diagnosis and interpretation of steatosis and steatohepatitis.

Burt AD, Mutton A, Day CP. Burt AD, et al. Semin Diagn Pathol. 1998 Nov;15(4):246-58. Semin Diagn Pathol. 1998. PMID: 9845426 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters